Jones v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided August 26, 2024·No. 19-0788V·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-788V Filed: August 1, 2024

* * * * * * * * * * * * * * * PATTY BOON, Trustee for the heirs of * CHARLEY BOON, * * Petitioner, * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * *

Randall Knutson, Esq., Knutson & Casey Law Firm, Mankato, MN, for petitioner. Tyler King, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On May 29, 2019, Charley Boon2 filed a petition for compensation under the National Vaccine Injury Compensation Program3 alleging that he developed Guillain-Barré Syndrome (“GBS”) as a result of the influenza (“flu”) vaccine he received on September 27, 2016. Petition, ECF No. 1. Petitioner now seeks an award of interim attorneys’ fees and costs.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 On December 27, 2019, petitioner filed a status report advising that Mr. Boon passed away. ECF No. 19. A Motion to Substitute was filed on August 19, 2020, and Mr. Boon’s wife Patty Boon continued with the matter as his trustee. ECF No. 27. 3 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). I. Procedural History

The petition was filed on May 29, 2019, and the matter was assigned to the undersigned the following day. ECF Nos. 1, 4. Petitioner filed medical records, an expert report from Dr. James Dahlgren, and a statement of completion on June 14, 2019. Petitioner’s Exhibit (“Pet. Ex.”) 1-27, ECF Nos. 7-10.

Petitioner filed additional medical records and the literature associated with Dr. Dahlgren’s report on December 9, 2019 and December 26, 2019. Pet. Ex. 28-48, ECF Nos. 15-17. On December 27, 2019, petitioner’s counsel filed a status report advising that Mr. Boon had passed away and requesting time to have his wife appointed as trustee in order to continue pursuing the claim. ECF No. 19. His death certificate was also filed. ECF No. 18.

Petitioner filed a Motion to substitute and documentation supporting the appointment of petitioner’s wife Patty Boon as his trustee. The motion was granted. Pet. Ex. 50, ECF Nos. 26-28.

Petitioner filed additional medical records and a statement of completion on October 1, 2020. Pet. Ex. 51-54, ECF Nos. 29-30. On January 25, 2021, respondent filed his Rule 4(c) Report, recommending against compensation in this matter and noting that while the injury alleged in the petition is GBS, Mr. Boon was ultimately diagnosed with and treated for CIDP. ECF No. 32 at 19- 20. Petitioner was ordered to file a supplemental report from Dr. Dahlgren that addressed all the issues raised in the Rule 4(c) Report, including Mr. Boon’s diagnosis. ECF No. 33.

Petitioner filed a supplemental report from Dr. Dahlgren on April 27, 2021, and corresponding medical literature on June 11, 2021. Pet. Ex. 55-63, ECF Nos. 34-35. Thereafter, respondent filed an expert report and medical literature from Dr. Jamieson. Respondent’s Exhibit (“Resp. Ex.”) A-B, ECF Nos. 36-39.

On August 2, 2021, petitioner filed a third report from Dr. Dahlgren, Pet. Ex. 64, ECF No. 40. On December 15, 2021, respondent filed responsive reports from Dr. Jamieson and Dr. He. Resp. Ex. C-E, ECF Nos. 46-47. Petitioner filed a fourth report from Dr. Dahlgren with additional literature on March 4, 2022. Pet. Ex. 65-72, ECF No. 49.

A status conference was held on April 27, 2022, during which the matter as a whole and the opinions of the experts were reviewed in detail. Specifically, the deficiencies of Dr. Dahlgren’s reports were highlighted, and the undersigned noted that, based on the record as it stood at that time, the matter should be dismissed. Petitioner was ordered to file a status report advising how she intended to proceed. ECF No. 50.

On June 7, 2022, petitioner filed a document titled “Motion for Ruling on the Record,” which contained little more than that she had submitted all the evidence she intended and requested a ruling on the record. ECF No. 52. Petitioner was subsequently ordered to file a more detailed submission that included petitioner’s argument in the matter with citations to the record in support of the motion. ECF No. 53. Petitioner filed a memorandum to the Motion for Ruling on the Record on August 11, 2022. ECF No. 54. Respondent filed a response on October 26, 2022, and petitioner

2 filed a status report on November 11, 2022, stating that she did not intend to file a reply. ECF Nos. 57-58.

On April 12, 2024, petitioner filed a Motion for Interim Attorneys’ Fees and Costs. Motion for Interim Fees, ECF No. 59. Petitioner requests a total of $81,747.14, representing $58,099.25 in attorneys’ fees and $23,647.89 in costs. Motion for Interim Fees at 1. Respondent filed a response on April 24, 2024, deferring to the undersigned to determine whether the statutory requirements and legal standard for an award of interim attorneys’ fees and costs were met. Response, ECF No. 60. Petitioner did not file a reply.

This matter is now ripe for determination.

II. Legal Framework

The Vaccine Act permits an award of reasonable attorneys’ fees and other costs. § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, petitioner’s counsel is automatically entitled to reasonable attorneys’ fees. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008). Under this approach, “an initial estimate of a reasonable attorneys’ fee” is calculated by “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Id. at 1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). That product is then adjusted upward or downward based on other specific findings. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Jones v. Secretary of Health and Human Services, (uscfc 2024).

Jones v. Secretary of Health and Human Services (Jones v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related